home / stock / nrxp / nrxp quote
Last: | $0.4719 |
---|---|
Change Percent: | 0.0% |
Open: | $0.48 |
Close: | $0.4719 |
High: | $0.54 |
Low: | $0.4155 |
Volume: | 2,575,629 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.4719 | $0.48 | $0.4719 | $0.54 | $0.4155 | 2,575,629 | 03-29-2024 |
$0.4719 | $0.48 | $0.4719 | $0.54 | $0.4155 | 2,530,377 | 03-28-2024 |
$0.53 | $0.5293 | $0.53 | $0.55 | $0.51 | 360,460 | 03-27-2024 |
$0.516 | $0.5381 | $0.516 | $0.55 | $0.51 | 543,993 | 03-26-2024 |
$0.53 | $0.5491 | $0.53 | $0.58 | $0.5207 | 766,822 | 03-25-2024 |
$0.56 | $0.52 | $0.56 | $0.6 | $0.51 | 3,572,976 | 03-22-2024 |
$0.5051 | $0.49 | $0.5051 | $0.528 | $0.47 | 1,048,100 | 03-21-2024 |
$0.485 | $0.48 | $0.485 | $0.4961 | $0.46 | 686,390 | 03-20-2024 |
$0.481 | $0.527 | $0.481 | $0.54 | $0.4716 | 1,100,658 | 03-19-2024 |
$0.515 | $0.4665 | $0.515 | $0.57 | $0.46 | 1,979,125 | 03-18-2024 |
$0.4551 | $0.412 | $0.4551 | $0.4698 | $0.412 | 951,182 | 03-15-2024 |
$0.426 | $0.47 | $0.426 | $0.4859 | $0.425 | 754,256 | 03-14-2024 |
$0.463 | $0.45 | $0.463 | $0.49 | $0.45 | 1,483,836 | 03-13-2024 |
$0.4394 | $0.5767 | $0.4394 | $0.5767 | $0.405 | 6,065,932 | 03-12-2024 |
$0.669 | $0.64 | $0.669 | $0.72 | $0.62 | 3,749,330 | 03-11-2024 |
$0.6134 | $0.6412 | $0.6134 | $0.65 | $0.6 | 1,969,621 | 03-08-2024 |
$0.659 | $0.69 | $0.659 | $0.705001 | $0.6478 | 1,779,811 | 03-07-2024 |
$0.7006 | $0.7 | $0.7006 | $0.73 | $0.565 | 4,968,899 | 03-06-2024 |
$0.663 | $0.55 | $0.663 | $0.7333 | $0.55 | 13,134,772 | 03-05-2024 |
$0.52 | $0.43 | $0.52 | $0.5499 | $0.425 | 4,668,347 | 03-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
NRX Pharmaceuticals Inc. Company Name:
NRXP Stock Symbol:
NASDAQ Market:
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights PR Newswire Four potential near-term milestones, including data from two clinical trials, an NDA filing and a share dividend RAD...
NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing PR Newswire Common Stock Will Begin Trading on Split-Adjusted Basis on April 2, 2024 RADNOR, Pa. , March 28, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx ...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...